Complementation Analysis of Carnitine Palmitoyltransferase I and II Defects

Carnitine palmitoyltransferase (CPT) consists of two activities located in the outer (CPT I) and the inner (CPT II) mitochondrial membranes. CPT II deficiency in the adult as well as in the infantile form of the disease has been shown to result from mutations in the CPT II cDNA. Nothing is known regarding the genetic defect in CPT I deficiency. We carried out complementation experiments between CPT I- and infantile CPT II-deficient cell lines. Restoration of 3H2O release from[9,10(n)-3H]-palmitate was chosen as criterion of complementation. As expected, no complementation was observed in heteropolykaryons resulting from fusions between CPT II-deficient cells. Similar results were obtained in fusions between CPT I-deficient cells, suggesting that the enzymatic defect in these cell lines results from mutations in the same gene. Conversely, complementation was observed in fusions between CPT I- and CPT II-deficient cells. These data support that CPT I and CPT II defects result from mutations in distinct genes. Palmitate oxidation by control or CPT I-deficient cell lines was decreased when cocultured with infantile CPT II-deficient cell lines. This effect, not observed in coculture including an adult CPT II-deficient cell line, was carnitine-dependent. The possible mechanism of this effect, suppressed by a high carnitine concentration, is discussed.

[1]  William,et al.  Purification of human very-long-chain acyl-coenzyme A dehydrogenase and characterization of its deficiency in seven patients. , 1995, The Journal of clinical investigation.

[2]  J. McGarry,et al.  Human liver mitochondrial carnitine palmitoyltransferase I: characterization of its cDNA and chromosomal localization and partial analysis of the gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[3]  F. Taroni,et al.  Identification of a common mutation in the carnitine palmitoyltransferase II gene in familial recurrent myoglobinuria patients , 1993, Nature Genetics.

[4]  S. Pande,et al.  Carnitine-acylcarnitine translocase deficiency with severe hypoglycemia and auriculo ventricular block. Translocase assay in permeabilized fibroblasts. , 1993, The Journal of clinical investigation.

[5]  G. Finocchiaro,et al.  Molecular characterization of inherited carnitine palmitoyltransferase II deficiency. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[6]  K. Bove,et al.  Lethal neonatal multiorgan deficiency of carnitine palmitoyltransferase II. , 1991, The New England journal of medicine.

[7]  D. Valle,et al.  Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake , 1991, Annals of neurology.

[8]  J. Saudubray,et al.  Infantile form of carnitine palmitoyltransferase II deficiency with hepatomuscular symptoms and sudden death. Physiopathological approach to carnitine palmitoyltransferase II deficiencies. , 1991, The Journal of clinical investigation.

[9]  M. Rocchi,et al.  cDNA cloning, sequence analysis, and chromosomal localization of the gene for human carnitine palmitoyltransferase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[10]  C. Slaughter,et al.  Cloning, sequencing, and expression of a cDNA encoding rat liver mitochondrial carnitine palmitoyltransferase II. , 1990, The Journal of biological chemistry.

[11]  J. Saudubray,et al.  Immunoquantitative Analysis of Human Carnitine Palmitoyltransferase I and II Defects , 1990, Pediatric Research.

[12]  S. Donato,et al.  Hepatic and Muscular Presentations of Carnitine Palmitoyl Transferase Deficiency: Two Distinct Entities , 1988, Pediatric Research.

[13]  P E Declercq,et al.  Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system. I. Use of inhibitors. , 1987, The Journal of biological chemistry.

[14]  D. Kelly,et al.  Nucleotide sequence of medium-chain acyl-CoA dehydrogenase mRNA and its expression in enzyme-deficient human tissue. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[15]  H. Lund Carnitine palmitoyltransferase: characterization of a labile detergent-extracted malonyl-CoA-sensitive enzyme from rat liver mitochondria. , 1987, Biochimica et biophysica acta.

[16]  R. Nordmann,et al.  Carnitine palmitoyltransferase I. Inhibition by D-galactosamine and role of phospholipids. , 1983, European journal of biochemistry.

[17]  C. Long,et al.  Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. , 1983, The Biochemical journal.

[18]  K. Gibson,et al.  Oxidation of Fatty Acids in Cultured Fibroblasts: a Model System for the Detection and Study of Defects in Oxidation , 1982, Pediatric Research.

[19]  P. Bougnères,et al.  Fasting hypoglycemia resulting from hepatic carnitine palmitoyl transferase deficiency. , 1981, The Journal of pediatrics.

[20]  B. Migeon,et al.  Enrichment of human heterokaryons by ficoll gradient for complementation analysis of iduronate sulfatase deficiency , 1979, Somatic cell genetics.

[21]  J. McGarry,et al.  Carnitine palmitoyltransferase I. The site of inhibition of hepatic fatty acid oxidation by malonyl-CoA. , 1978, The Journal of biological chemistry.

[22]  S. Dimauro,et al.  Muscle Carnitine Palmityltransferase Deficiency and Myoglobinuria , 1973, Science.

[23]  G. Finocchiaro,et al.  Carnitine palmitoyltransferase II deficiency: structure of the gene and characterization of two novel disease-causing mutations. , 1995, Human molecular genetics.

[24]  J. Saudubray,et al.  Pathophysiological approach to carnitine palmitoyltransferase II deficiencies. , 1992, Progress in clinical and biological research.

[25]  W. Rhead,et al.  Complementation analysis of fatty acid oxidation disorders. , 1987, The Journal of clinical investigation.

[26]  M. S. Murthy,et al.  Malonyl-CoA binding site and the overt carnitine palmitoyltransferase activity reside on the opposite sides of the outer mitochondrial membrane. , 1987, Proceedings of the National Academy of Sciences of the United States of America.